Palo Alto Investors Sells Out Of Savient Pharmaceuticals

William Leland Edwards' fund, Palo Alto Investors, just reported cutting down its entire position in nano-cap company Savient Pharmaceuticals Inc (OTCMKTS:SVNTQ). In its latest 13F, Palo Alto revealed holding over 9.74 million shares of Savient.

Savient Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Phil Frohlich, Prescott Still Loading Up on China Marine Food Group

Hillhouse Capital Management Discloses New Stake in Qunar Cayman Islands

Noam Gottesman, GLG Partners Are Bullish on Tableau Software

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks